Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-02

Clinical Trial Update: Vaginal Creams to Reduce Vaginal Erosion in Pessary Users [Phase 2]

View source ↗

Summary

Phase 2 trial of vaginal creams to reduce vaginal erosion in pessary users has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwell Health | Conditions: Atrophy of Vagina, Vaginal Ulceration | Phase 2 | Status: WITHDRAWN